Literature DB >> 11807178

Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.

Stephane Angers1, Ali Salahpour, Michel Bouvier.   

Abstract

In the last four to five years, the view that G protein-coupled receptors (GPCRs) function as monomeric proteins has been challenged by numerous studies, which suggests that GPCRs exist as dimers or even higher-structure oligomers. Recently, biophysical methods based on luminescence and fluorescence energy transfer have confirmed the existence of such oligomeric complexes in living cells. Although no consensus exists on the role of receptor dimerization, converging evidence suggests potential roles in various aspects of receptor biogenesis and function. In several cases, receptors appear to fold as constitutive dimers early after biosynthesis, whereas ligand-promoted dimerization at the cell surface has been proposed for others. The reports of heterodimerization between receptor subtypes suggest a potential level of receptor complexity that could account for previously unexpected pharmacological diversities. In addition to fundamentally changing our views on the structure and activation processes of GPCRs, the concept of homo- and heterodimerization could have dramatic impacts on drug development and screening.

Mesh:

Substances:

Year:  2002        PMID: 11807178     DOI: 10.1146/annurev.pharmtox.42.091701.082314

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  149 in total

1.  Mont Sainte-Odile: a sanctuary for GPCRs. Confidence on signal transduction of G-protein-couple receptors.

Authors:  Barbara Moepps; Laurent Fagni
Journal:  EMBO Rep       Date:  2003-03       Impact factor: 8.807

Review 2.  Roles of G-protein-coupled receptor dimerization.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

Review 3.  Multiple serotonergic mechanisms contributing to sensitization in aplysia: evidence of diverse serotonin receptor subtypes.

Authors:  Demian Barbas; Luc DesGroseillers; Vincent F Castellucci; Thomas J Carew; Stéphane Marinesco
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

4.  The G protein-coupled receptor rhodopsin in the native membrane.

Authors:  Dimitrios Fotiadis; Yan Liang; Slawomir Filipek; David A Saperstein; Andreas Engel; Krzysztof Palczewski
Journal:  FEBS Lett       Date:  2004-04-30       Impact factor: 4.124

5.  Receptor activity-independent recruitment of betaarrestin2 reveals specific signalling modes.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

6.  A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.

Authors:  Ivone Gomes; Achla Gupta; Julija Filipovska; Hazel H Szeto; John E Pintar; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

Review 7.  Purinergic-receptor oligomerization: implications for neural functions in the central nervous system.

Authors:  Hiruyasu Nakata; Kazuaki Yoshioka; Toshio Kamiya
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

8.  Structural aspects of M₃ muscarinic acetylcholine receptor dimer formation and activation.

Authors:  Jianxin Hu; Doreen Thor; Yaru Zhou; Tong Liu; Yan Wang; Sara M McMillin; Rajendra Mistry; R A John Challiss; Stefano Costanzi; Jürgen Wess
Journal:  FASEB J       Date:  2011-10-26       Impact factor: 5.191

9.  Opioid activity of spinally selective analogues of N-naphthoyl-β-naltrexamine in HEK-293 cells and mice.

Authors:  Morgan Le Naour; Mary M Lunzer; Mike D Powers; Philip S Portoghese
Journal:  J Med Chem       Date:  2012-01-05       Impact factor: 7.446

10.  Functional characterization of rhodopsin monomers and dimers in detergents.

Authors:  Beata Jastrzebska; Tadao Maeda; Li Zhu; Dimitrios Fotiadis; Slawomir Filipek; Andreas Engel; Ronald E Stenkamp; Krzysztof Palczewski
Journal:  J Biol Chem       Date:  2004-10-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.